Nadia Abu El Haj

Nadia Abu El-Haj (; born 1962) is an American anthropologist at Barnard College and Columbia University.

The author of ''Facts on the Ground: Archaeological Practice and Territorial Self-Fashioning in Israeli Society'' (2001) and ''The Genealogical Science: The Search for Jewish Origins and the Politics of Epistemology'' (2012), Abu El-Haj was the subject of dueling online petitions arguing whether she should be tenured during the 2006–07 academic year when she was recommended for tenure. Abu El-Haj received tenure in November 2007. Provided by Wikipedia
Showing 1 - 10 results of 10 for search 'Nadia Haj', query time: 0.04s Refine Results
  1. 1
    Synthesis and Pharmacological Characterization of Metronidazole-Oxadiazole Derivatives

    Synthesis and Pharmacological Characterization of Metronidazole-Oxadiazole Derivatives by Mohsin Mohammed, Nadia Haj

    Published 2023-03-01
    Get full text
    Article
  2. 2
    Capecitabine, 5-fluorouracil and S-1 based regimens for previously untreated advanced oesophagogastric cancer: A network meta-analysis

    Capecitabine, 5-fluorouracil and S-1 based regimens for previously untreated advanced oesophagogastric cancer: A network meta-analysis by Emil ter Veer, Lok Lam Ngai, Gert van Valkenhoef, Nadia Haj Mohammad, Maarten C. J. Anderegg, Martijn G. H. van Oijen, Hanneke W. M. van Laarhoven

    Published 2017-08-01
    Get full text
    Article
  3. 3
    Effects of dietary methionine and cysteine restriction on plasma biomarkers, serum fibroblast growth factor 21, and adipose tissue gene expression in women with overweight or obesity: a double-blind randomized controlled pilot study

    Effects of dietary methionine and cysteine restriction on plasma biomarkers, serum fibroblast growth factor 21, and adipose tissue gene expression in women with overweight or obesi... by Thomas Olsen, Bente Øvrebø, Nadia Haj-Yasein, Sindre Lee, Karianne Svendsen, Marit Hjorth, Nasser E. Bastani, Frode Norheim, Christian A. Drevon, Helga Refsum, Kathrine J. Vinknes

    Published 2020-03-01
    Get full text
    Article
  4. 4
    Stereotactic radiotherapy or metastasectomy for oligometastatic esophagogastric cancer: A nationwide population-based cohort study

    Stereotactic radiotherapy or metastasectomy for oligometastatic esophagogastric cancer: A nationwide population-based cohort study by Tiuri E. Kroese, Nikita K.N. Jorritsma, Hanneke W.M. van Laarhoven, Rob H.A. Verhoeven, Stella Mook, Nadia Haj Mohammad, Jelle P. Ruurda, Peter S.N. van Rossum, Richard van Hillegersberg

    Published 2022-11-01
    Get full text
    Article
  5. 5
    A population-based study in synchronous metachronous metastatic esophagogastric adenocarcinoma

    A population-based study in synchronous metachronous metastatic esophagogastric adenocarcinoma by Marieke Pape, Pauline A. J. Vissers, David Bertwistle, Laura McDonald, Marije Slingerland, Nadia Haj Mohammad, Laurens V. Beerepoot, Jelle P. Ruurda, Grard A. P. Nieuwenhuijzen, Paul M. Jeene, Hanneke W. M. van Laarhoven, Rob H. A. Verhoeven

    Published 2022-03-01
    Get full text
    Article
  6. 6
    Trends in Treatment and Survival of Gallbladder Cancer in the Netherlands; Identifying Gaps and Opportunities from a Nation-Wide Cohort

    Trends in Treatment and Survival of Gallbladder Cancer in the Netherlands; Identifying Gaps and Opportunities from a Nation-Wide Cohort by Elise de Savornin Lohman, Tessa de Bitter, Rob Verhoeven, Lydia van der Geest, Jeroen Hagendoorn, Nadia Haj Mohammad, Freek Daams, Heinz-Josef Klümpen, Thomas van Gulik, Joris Erdmann, Marieke de Boer, Frederik Hoogwater, Bas Groot Koerkamp, Andries Braat, Joanne Verheij, Iris Nagtegaal, Cornelis van Laarhoven, Peter van den Boezem, Rachel van der Post, Philip de Reuver

    Published 2020-04-01
    Get full text
    Article
  7. 7
    Longitudinal immune monitoring of patients with resectable esophageal adenocarcinoma treated with Neoadjuvant PD-L1 checkpoint inhibition

    Longitudinal immune monitoring of patients with resectable esophageal adenocarcinoma treated with Neoadjuvant PD-L1 checkpoint inhibition by Tom van den Ende, Aiarpi Ezdoglian, Lisanne M. Baas, Joyce Bakker, Sinéad M. Lougheed, Micaela Harrasser, Cynthia Waasdorp, Mark I. van Berge Henegouwen, Maarten C.C.M. Hulshof, Nadia Haj Mohammad, Richard van Hillegersberg, Stella Mook, Conny J. van der Laken, Nicole C.T. van Grieken, Sarah Derks, Maarten F. Bijlsma, Hanneke W.M. van Laarhoven, Tanja D. de Gruijl

    Published 2023-12-01
    Get full text
    Article
  8. 8
    SOURCE: A Registry-Based Prediction Model for Overall Survival in Patients with Metastatic Oesophageal or Gastric Cancer

    SOURCE: A Registry-Based Prediction Model for Overall Survival in Patients with Metastatic Oesophageal or Gastric Cancer by Héctor G. van den Boorn, Ameen Abu-Hanna, Emil ter Veer, Jessy Joy van Kleef, Florian Lordick, Michael Stahl, Jaffer A. Ajani, Rosine Guimbaud, Se Hoon Park, Susan J. Dutton, Yung-Jue Bang, Narikazu Boku, Nadia Haj Mohammad, Mirjam A.G. Sprangers, Rob H.A. Verhoeven, Aeilko H. Zwinderman, Martijn G.H. van Oijen, Hanneke W.M. van Laarhoven

    Published 2019-02-01
    Get full text
    Article
  9. 9
    A Phase II Study Demonstrates No Feasibility of Adjuvant Treatment with Six Cycles of S-1 and Oxaliplatin in Resectable Esophageal Adenocarcinoma, with ERCC1 as Biomarker for Response to SOX

    A Phase II Study Demonstrates No Feasibility of Adjuvant Treatment with Six Cycles of S-1 and Oxaliplatin in Resectable Esophageal Adenocarcinoma, with ERCC1 as Biomarker for Respo... by Charlotte I. Stroes, Sandor Schokker, Remco J. Molenaar, Ron A. A. Mathôt, Maarten F. Bijlsma, Stephanie O. van der Woude, João P. Belo Pereira, Gerrit K. J. Hooijer, Rob H. A. Verhoeven, Annemieke Cats, Cecile Grootscholten, Johanna W. van Sandick, Geert-Jan Creemers, Grard A. P. Nieuwenhuijzen, Nadia Haj Mohammad, Jelle P. Ruurda, Sybren L. Meijer, Maarten C. C. M. Hulshof, Mark I. van Berge Henegouwen, Hanneke W. M. van Laarhoven

    Published 2021-02-01
    Get full text
    Article
  10. 10
    Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6)

    Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases:... by Koen P. Rovers, Checca Bakkers, Geert A. A. M. Simkens, Jacobus W. A. Burger, Simon W. Nienhuijs, Geert-Jan M. Creemers, Anna M. J. Thijs, Alexandra R. M. Brandt-Kerkhof, Eva V. E. Madsen, Ninos Ayez, Nadine L. de Boer, Esther van Meerten, Jurriaan B. Tuynman, Miranda Kusters, Nina R. Sluiter, Henk M. W. Verheul, Hans J. van der Vliet, Marinus J. Wiezer, Djamila Boerma, Emma C. E. Wassenaar, Maartje Los, Cornelis B. Hunting, Arend G. J. Aalbers, Niels F. M. Kok, Koert F. D. Kuhlmann, Henk Boot, Myriam Chalabi, Schelto Kruijff, Lukas B. Been, Robert J. van Ginkel, Derk Jan A. de Groot, Rudolf S. N. Fehrmann, Johannes H. W. de Wilt, Andreas J. A. Bremers, Philip R. de Reuver, Sandra A. Radema, Karin H. Herbschleb, Wilhelmina M. U. van Grevenstein, Arjen J. Witkamp, Miriam Koopman, Nadia Haj Mohammad, Eino B. van Duyn, Walter J. B. Mastboom, Leonie J. M. Mekenkamp, Joost Nederend, Max J. Lahaye, Petur Snaebjornsson, Cornelis Verhoef, Hanneke W. M. van Laarhoven, Aeilko H. Zwinderman, Jeanette M. Bouma, Onno Kranenburg, Iris van ‘t Erve, Remond J. A. Fijneman, Marcel G. W. Dijkgraaf, Patrick H. J. Hemmer, Cornelis J. A. Punt, Pieter J. Tanis, Ignace H. J. T. de Hingh, Dutch Peritoneal Oncology Group (DPOG), Dutch Colorectal Cancer Group (DCCG)

    Published 2019-04-01
    Get full text
    Article

Search Tools: